Transcript:
CONWAY GITTENS: I’m Conway Gittens reporting from the New York Stock Exchange. Here’s what we’re watching on TheStreet today.
Investors are digesting another round of quarterly results, this time from Nike, Micron, Walgreens, and Levi Strauss. This is the final trickle of first-quarter results ahead of the start of the second-quarter reporting season.
On the economic front, weekly jobless claims fell for the second straight week but in a sign it’s taking longer to find a job, the number of Americans receiving unemployment benefits beyond the first week surged to a 2.5 year high. Investors now eagerly await Friday’s PCE inflation data.
In other news… despite what it may promise on the bottle, taking a daily multivitamin doesn’t actually help to add years to your life.
Watch More Videos:
New dyslexia treatment aims to overcome biggest hurdle in cognitive healthcareHow this YouTuber built a huge audience by playing slotsYes, there are fewer chips in the bag: Shrinkflation, explained
A recent study by the National Institutes of Health “did not find evidence to support improved longevity among healthy adults who regularly take multivitamins.” In fact, the study found that taking a daily multivitamin supplement boosted the chance of death by 4 percent.
The 20-year study, published in the Journal of the American Medical Association, involved nearly 400,000 people without major health issues. The median age of participants was 61-and-a-half.
This won’t be welcomed news for the 1 in 3 Americans who take daily multivitamin supplements. Sales of those supplements are estimated to bring in $45 billion to manufacturers in 2024.
That’ll do it for your daily briefing. From the New York Stock Exchange, I’m Conway Gittens with TheStreet.
Related: Stock Market Today: Stocks edge higher, Micron weighs on big tech
